In this study we evaluated the antiinflammatory and anti-granuloma activity of standardized Terminalia chebula hydroalcoholic extract (TCHE) in experimental models. Adult male Wistar rats from Our institutional breeding stock were used in this study. TCHE was orally administered to three groups of animals at 20mg/, 40mg/ and 80mg/kg, respectively. Indomethacin (3mg/kg) was used as the reference drug. TCHE and indomethacin was suspended in 1% gum acacia and administered by gavage, according to treatment protocols for different models. Anti-inflammatory activity was evaluated by using the carrageenan-induced paw edema in rats. The effect on macrophages was studied by using subcutaneous cotton pellet implantation-induced granuloma formation and stimulation of peritoneal macrophages using complete Freund's adjuvant (CFA) in Wistar rats. Circulating TNF-alpha, IL-6, fL-l beta levels and mllcrophage expression of TNF-R 1 was evaluated as marker of global inflammation. Although there was a decrease in paw edema in all TCHE treated groups, significant reduction (p<O.05) against control was only observed in the highest dose treated group, 3 h post carrageenan administration. In the cotton pellet-induced granuloma model, there was a significant reduction (p<O.05) in dry granuloma weight and circulnting TNF-nlpha, IL-6 and IL-lbeta levels in the TCHE (80mg/kg) treated group as compared to control. Immunoblot analysis for TNF-Rl expression in CFA-stimulated peritoneal macrophages also d~monstrated a significant reduction (p<O.OS) in receptor protein expression after TCHE treatment. Result of the present study thus demonstrates the anti-granuloma activity ofTCHE in experimental models.
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In the pathophysiology of chronic inflammatory and granulomatous diseases, macrophage activation and dysfunction are known to contribute towards both nai ntel 1ance and progression of the disease state, as IS evident by the elevated levels of predominantly macrophage-derived proinflarnmatory cytokines viz. TNF-alpha, IL-6 and IL-I beta in these conditions (I, 2). One such granulomatous condition is Rheumatoid arthritis (RA), where it has been hypothesized that :Ictivation of macrophagcs is a global phenomenon 1I1volving both local synovial macrophages as well as circulating monocytes (3).
In a previous report we demonstrated the disease-modifying activity of Terminalia chebula hydroalcoholic extract (TCHE) in complete Freund's adjuvant (CFA) induced arthritis in Wistar rats (4). Evaluated markers of disease activity, viz. joint swelling, serum and synovial expression of proinflammatory cytokines, were found to be reduced in the TCI-IE-treated animals as compared to vehicle control. However, as similar results were also observed in the indomethacin-treated group, we could not differentiate whether the observed effects were primarily due to inhibition of prostaglandin synthesis or due to an inhibitory activity against proinflammatory cells. Additionally, there is also the involvement of fibroblasts and other leukocytes along with macro phages in development of this disease state which could have contributed towards proinflammatory cytokine levels (3, 5) .
Therefore, in the present study we investigated the anti-inflammatory activity ofTCHE in carrageenaninduced paw edema model to evaluate the involvement of anti-inflammatory activity at the doses tested. Evaluation of the inhibitory activity of TCHE on macrophages was carried out in subcutaneous cotton pellet implantation-induced granuloma model as it is depictive of circulating macrophage activation and aggregation (6) . Serum levels of proinflammatory cytokines (TNF-alpha, IL-6 and IL-Ibeta) were estimated as markers of global inflammation. TNF-RI expression on peritoneal macrophage was also estimated, as this receptor has been implicated in most of the pathophysiological actions of TNFalpha (7, 8) .
MATERIALS AND METHODS

Animals
Adult male Wistar albino rats (l50-180 g) from our institutional breeding stoek were housed at 25±2°C in clean polypropylene cages in groups of 3 with free access to standard pellet diet and drinking water. Experiments were carried out after approval of protocol by the Institutional Animal Ethics Committee, All India Institute of Medical Sciences, New Delhi, and in accordance with 'Guidelines for care and use of animals in scientific research (Indian National Science Academy 1998, Revised 2(00)'.
Test drug
Terminalla chebula Retz. hydroalcoholie (50%) methanol) extract [TCHE: reported by us in a previous study (4)] was brownish-black in colour and the total quantitative yield was 32.00% w/w. It was found to contain tannins and sugars as the most abundant secondary metabolites. The total tannin content in Terminalia chebula (TC), as determined earlier by spectrophotometry was 30.32% w/w. TCHE was standardized on the basis of chebulagic acid content as determined by RP-HPLC (AG lLENT 1200 system) and was found-to contain 10.2% w/w chebuJagic acid (4). Toxicity studies on the test compound had already demonstrated an LD50 value >2000mg/kg and absence of significant physiological changes at.a dose of 400mg/kg for twenty eight days (4);
Carrageenan administration induced paw edema in rats
The experimental protocol and methodologies used by us in this study are similar to those employed by us in a previous report (9) . Animals were divided into five groupS (n=6) and fasted overnight with access to water ad libitum. Thereafter, group I received vehicle (1% gum acacia) and served as the control, group II received standard drug indomethacin (3mg/kg) and groups III, IV and V received TCHE at a dose of 20mg/, 40mg/ and 80mg/ kg respectively. Sixty minutes post administration of the drug/vehicle, paw edema was induced by subcutaneous administration of0.1 ml, of 1% A-carrageenan (constituted in normal saline) into the left hind paw of the animal (10). Paw edema was measured using a digital plethysmometer (Ugo Basile, Italy) at I h, 3 hand 6 h post-carrageenan administration.
Subcutaneous cotton pellet implantation induced granuloma formation
Animals were divided into five groups (n=6) and maintained under aseptic conditions for the entire duration of the study. Grouping of animals and drug treatment was similar to the method described above. Thirty minutes after administration of drug/vehicle the animals were anaesthetized with diethyl-ether and a sterile cotton pellet (made of bleached cotton weighing 30± I mg) saturated' with normal saline was implanted subcutaneously bilaterally below the axilla as described earlier (9) . The day of cotton pellet implantation was designated as Day O. Respective treatment of the groups was continued for the duration of 6 more days. On day 7, terminal blood collection was carried out and the cotton pellets were excised. Serum was separated by centrifuging at 3000 rpm and used for estimation of circulating cytokines. The pellets were dried overnight in a hot air oven at 60°C till a constant weight was recorded at two consecutive time points. The difference between the initial and post implantation weight was considered to be the dry weight of granuloma tissue (II).
Estimation ofserum cytokine levels
A commercial ELISA kit (U-CyTech Bioscicnces, The Netherlands) was used for estimation of serum TNF-alpha levels. Measurement of lL-6 and IL-I beta protein was carried out by dot-blot analysis of serum, as described earlier (9) .
CFA induced stimulation ofperitoneal macrophages
Three groups (n=3) of male Wistar albino rats were used in the study. After overnight fasting group I was administered vehicle (I % gum acacia) and served as the control, group II was administered indomethacin (3mg/ kg) and group III was administered TCHE (80mg/kg) RESULTS did not produce significant activity post-carrageenan by gavage. Thirty minutes after administration of drug! vehicle, 0.1 mL of CFA (0.05%w/v dead Mycobacterium butyricum in mineral oil) was injected into the peritoneal cavity using a 26 gauge needle (12) . This was designated as Day O. Respective treatment was continued for the duration of 6 more days. On day 7, the animals were sacrificed by an overdose of anaesthetic ether. Peritoneal macrophages were collected and purified by culture as described by us earlier (9) .
Preparation ofcel/lysate and Western blotting:
The macrophage pellets were lysed by vortexing in I00 iu, of lysis buffer containing 50 mM Tris-HCI (pH 7.4), 300 mM NaCI, 0.5% (v/v) Triton X-IOO, 5 mM EDTA with 2 mM PMSF, lOmcg/rnl. leupcptin and 10UI mL aprotinin. The lysate was then kept on ice for 30 min and centrifuged at 10,000g for 15min at 4°C. Supernatant was collected and protein concentration was determined by Bradford method (13) using bovine serum albumin as the standard. 75 ug of protein was separated in 12% polyacrylamide gels (1.0 mrn thick), overlaid with a 4% stacking gel in SDS according to the standard procedure of Laemmli (14) . The separated proteins were transferred onto nitrocellulose membrane under an electric potential 15). The nitrocellulose membrane was processed and the IInmunoblots were developed as described by us earlier (9) .
Statistical analysis
Difference between groups was analysed by One-way ANOVA followed by Dunnett's Multiple Comparison (GraphPad InStat; Version 3.05). P<0.05 was considered significant.
rCHE treatment anti-inflammatory administration
Administration of carrageenan produced an increase in paw edema that was persistentthroughout the observation period. Maximum paw edema was observed at 6 h post-carrageenan administration in all the tested animals (Fig. I) . The standard drug, indomethacin, produced a significant reduction in paw edema at 3 hand 6 h post-carrageenan administration. Although there was a slight decrease in paw edema in the TCHE-treated groups as compared to control, this decrease was statistically significantonly at the highest dose (80mg/kg) tested, 3 h post-carrageenan administration.
rCNE treatment reduced granulomaformation after cotton pellet implantation Subcutaneous implantationof sterile cotton pellet led to the formation of granuloma tissue around the foreign body in all the tested animals (Fig. 2) . Treatment with both indomethacin and TCHE produced a decrease in the dry granuloma weight as compared to control. However, in the case of TCHE, this decrease in granuloma weight.was only significant at the higher two doses tested (40 and 80mglkg). At these doses, the anti-granuloma activity of TCHE was comparable to that of indomethacin (3mg/kg).
TCHE treatment reduced the circulating levels of proinfiammatory cytokines
Elevated circulating TNF-alpha level was observed in all the tested animals after subcutaneous cotton pellet implantation (Fig. 3) . Indomethacin treatment produced a~2 fold increase in circulating TCHE treatment produced a significant decrease in circulating IL-6 and IL-I beta levels as compared to control ( Fig. 4 and Fig. 5, respectively) . A significant decrease in circulating IL-6 level was also observed in the indomethacin-treated group as compared to controL No significant change in the IL-I beta levels was observed in the indomethacin-treated group.
TCHE treatment reduced TNF-Rl expression on peritoneal macrophage
After calculating the %IDV values separately for TNF-RI and p-actin, normalization of TNF-RI protein expression was carried out by determining the amount of TNF-Rl expressed per unit of p-actin [(%IDV-TNF-Rl / %IDV-p-actin) X 100] as described by us earlier (9) . Comparison of normalized data demonstrated a significant reduction in macrophage TNF-Rl protein expression in the indomethacin and TCHE (80mg/kg) treated groups as compared to control (Fig. 6 ). TCHE (80mg/kg) treatment produced a greater inhibition of TNF-RI expression as compared to indomethacin (3mg/kg).
DISCUSSION
Terminalia chebula Retz. (Family: Combretaceae) also known as 'chebulic/black myrobala' in English and 'haritaki' in Sanskrit is a medicinal plant widely distributed in the tropics. It is used in the treatment of gastrointestinal diseases, hepatomegaly, splenomegaly, chronic fever, anaemia, polyuria, metabolic disturbances, joint pain, rheumatoid arthritis and other inflammatory diseases by practitioners of traditional medicine (16, 17) . The principal chemical constituents present in unripe TC fruit are d-galloyl glucose and tannins viz. chebulagic acid, chebulinic acid, ellagic acid, syringic acid, gallic acid and chebulic acid (18) . Experimental studies with TC have demonstrated significant antiinflammatory and antiarthritic activity in animal and in-vitro models (4, [19] [20] [21] .
Carrageenan-induced paw edema is a widely used animal model for evaluation of antiinflammatory agents that have an inhibitory activity against autacoid mediators. The response to subcutaneously administered carrageenan is biphasic, with the initial phase (0-2 hours) being primarily mediated by amino acid-derived autacoids histamine and serotonin. The late phase (3-6 hours) is predominantly mediated by arachidonic acid derivatives (mainly prostaglandins), and kinins are involved in the transition between the initial and late phases (22) (23) (24) . In the present study, TCHE only produced a significant reduction in paw edema at 3 h post-carrageenan administration at the highest dose tested and this effect was not seen at 6 h. This indicates that TCHE may not be exerting significant anti-inflammatory activity at the doses tested in the present study.
The effect ofTCHE on macrophages was studied by using the cotton pellet implantation-induced granuloma model and CFA-mediated stimulation of peritoneal macrophages. The cotton pellet implantation model is considered to be a reliable in-vivo system for studying macrophage function, and efficacy in this model is depictive of inhibitory activity on macrophage activation, infiltration and
